Pharmacotherapy
- UE code MSBMM101
-
Schedule
36Quarter 1
- ECTS Credits 4
-
Language
Français
- General pharmacology
- Pharmacokinetics
- Microbiology
- Virology
- General pathology
- Chemistry, physiology, biochemistry
This course of pharmacotherapy is included in the first objective of the master of biomedical sciences.
"To understand all the steps in the development of new drugs, in particular of biotechnology or cellular origin"
Skills required
- Opening to the use of drugs in the hospital
- After the course, the students should be able to understand the major indications and the rational use of the most important drug categories, considering the underlying disease and the particular situation of the patient
- The students should also be able to make a systematic research on relevant databases (Pubmed, Cochrane,..) and to present orally a summary of a review on a pharmacotherapy topic.
- Reminders of pharmacokinetics and pharmacodynamics
- Cardiovascular disorders
- Hematologic and Oncologic disorders
- Hemostatic agents
- Pain and inflammation: Pr Jean-Michel Dogné
- Endocrinological disorders
- Gastrointestinal disorders (Crohn disease,...)
- Respiratory disorders
- Neurologic diseases
- Infectious diseases
Structure of the chapters
- Definition of the disease
- Physiopathology
- Clinical presentation
- Diagnosis
- Desired outcome
- Treatment: nonpharmacologic therapy, drug selection guidelines, dosing recommendations, adverse effects, pharmacokinetic considerations and important drug interactions
- Monitoring
2 parts
a) Oral presentation by the students (review paper): 20/100
Presentations
Answers to the questions
b) Oral examination: 80/100
- Oral 15 min (with 15min preparation)
- You will receive around 40-80 questions by the end of November
- English
-Content: all presentations, seminars, papers,…
The exact modalities of the evaluation are likely to be modified during the preparation of the examination schedules, depending on the practical constraints with which the faculty administration may be confronted, or in the event of illness / force majeure / encroachment with an internship, or because of the health situation related to the coronavirus.
- Oral presentations
- Scientific papers: reference books, review papers
- Presentation by students (in english)
- Reference books
- Seminars
- Podcasts
- Reference books:
a) M.Rowland, TN Tozer. Clinical Pharmacokinetics and Pharmacodynamics. 4st edition. 2010
b) J.Dipiro and coll. Pharmacotherapy. A pathophysiologic approach. 8st edition. 2011
c) B.Wells and coll. Pharmacotherapy handbook. 8st edition. 2011
Training | Study programme | Block | Credits | Mandatory |
---|---|---|---|---|
Master 120 en sciences biomédicales à finalité spécialisée en recherche préclinique | Standard | 0 | 4 | |
Master 120 en sciences biomédicales à finalité spécialisée en recherche clinique | Standard | 0 | 4 | |
Master 60 en sciences biomédicales | Standard | 0 | 4 | |
Master 120 en sciences biomédicales à finalité spécialisée en recherche préclinique | Standard | 1 | 4 | |
Master 120 en sciences biomédicales à finalité spécialisée en recherche clinique | Standard | 1 | 4 | |
Master 60 en sciences biomédicales | Standard | 1 | 4 |